Doximity (DOCS) Registers a Bigger Fall Than the Market: Important Facts to Note

Company Performance - Doximity's stock closed at $59.70, down 2.13% from the previous trading session, underperforming the S&P 500's loss of 0.3% [1] - The stock has decreased by 0.55% over the past month, while the Medical sector gained 0.76% and the S&P 500 increased by 3.64% [1] Earnings Forecast - Doximity is expected to release its earnings on August 7, 2025, with projected earnings per share (EPS) of $0.31, reflecting a 10.71% increase year-over-year [2] - Revenue is forecasted to be $139.67 million, indicating a 10.26% growth compared to the same quarter last year [2] Annual Estimates - For the annual period, the Zacks Consensus Estimates predict earnings of $1.46 per share and revenue of $625.72 million, representing increases of 2.82% and 9.7% respectively from the previous year [3] Analyst Revisions - Recent changes in analyst estimates for Doximity are important as they reflect short-term business trends, with positive revisions indicating a favorable business outlook [3][4] Zacks Rank - Doximity currently holds a Zacks Rank of 1 (Strong Buy), which has historically outperformed with an average annual return of +25% since 1988 [5] - The Zacks Consensus EPS estimate has remained steady over the past month [5] Valuation Metrics - Doximity has a Forward P/E ratio of 41.81, which is a premium compared to the industry average of 27.27 [6] - The company has a PEG ratio of 4.54, while the average PEG ratio for the Medical Info Systems industry is 2.66 [6] Industry Context - The Medical Info Systems industry ranks in the top 23% of all industries, with a current Zacks Industry Rank of 55 [7] - Strong individual industry groups, as measured by the Zacks Industry Rank, tend to outperform weaker groups by a factor of 2 to 1 [7]